JV
Chief Marketing Officer, Aulos Bioscience
MP
Chief Operating Officer & Co-Founder
Get the full picture
Sign in to uncover key details.
Aulos Bioscience
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
700 Larkspur Landing Cir Ste 108, Larksp...Phone Number
(212) 213-0006Website
www.aulosbio.comRevenue
<$5 MillionIndustry
About Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Aulos was created by ATP, a leading life science venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies, to initially develop unique IL2 targeting antibodies that it believes have the potential to become best-in-class treatments for solid tumors.Explore more
Aulos Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aulos Bioscience
Compare insights from companies similar to Aulos Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aulos Bioscience Tech Stack
A closer look at the technologies used by Aulos Bioscience
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aulos Bioscience
Sign Up For FreeTo access detailed company insights
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Aulos was created by ATP, a leading life science venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies, to initially develop unique IL2 targeting antibodies... Read More
